This inventor holds 9 USPTO granted patents. Top assignees: Astrazeneca Ab, Astra Aktiebolag. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2002
Title: Kostas Karabelas: Innovator in Pharmaceutical Compounds
Introduction
Kostas Karabelas is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 9 patents to his name, his work has had a considerable impact on medical research and drug development.
Latest Patents
Among his latest patents, Kostas has focused on pharmaceutically active compounds, specifically kinase inhibitors. These innovations are crucial in the treatment of various diseases, showcasing his commitment to advancing healthcare through scientific research.
Career Highlights
Kostas has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Astra Aktiebolag. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.
Collaborations
Throughout his career, Kostas has collaborated with esteemed colleagues such as Peter Sjö and Matti Lepistö. These partnerships have enriched his work and fostered an environment of innovation and creativity.
Conclusion
Kostas Karabelas stands out as a dedicated inventor in the pharmaceutical sector, with a strong portfolio of patents and a history of collaboration with industry leaders. His contributions continue to influence the development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile